Royalty Pharma: Q1 Earnings Insights

Royalty Pharma RPRX reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Royalty Pharma missed estimated earnings by 17.81%, reporting an EPS of $0.6 versus an estimate of $0.73.

Revenue was down $11.03 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 0.4% increase in the share price the next day.

Here's a look at Royalty Pharma's past performance:

To track all earnings releases for Royalty Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.